Cytomed Therapeutics Ltd. (GDTC)
Market Closed
16 Jun, 20:00
NASDAQ (CM) NASDAQ (CM) Primary 
XFRA $
1. 11
-0.04
-3.4783%
After Hours
$
+0.11 +9.9099% 1. 22
13.49M Market Cap
- P/E Ratio
- Div Yield
1,622 Volume
-0.26 Eps
$ 1.15
Previous Close Want to track GDTC and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Cytomed Therapeutics Ltd. (GDTC) Statistics
Valuation metrics
Market Cap 13.49M
Enterprise value 15.71M
Trailing P/E (ttm) -3.16
Forward P/E -
PEG ratio 0.12
Price/Sales (ttm) 34.02
Price/Book (mrq) 2.64
Enterprise Value/Revenue 30.85
Enterprise Value/EBITDA -3.18
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 34.16K
Average volume (90 days) 15.03K
Price summary
52-Week low 0.68
52-Week high 3.68
Beta -
50-Day moving average 1.05
200-Day moving average 1.15
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -10.71%
Operating margin -10.49%
Operational effectiveness
Return on assets -0.68%
Return on equity -0.73%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 0.04
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -0.46
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 0.18
Total debt (mrq) -
Total Debt/Equity (mrq) 0.07
Current ratio (mrq) 5.17%
Book value per share (mrq) 0.58
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
